Posted by: Audrey Erbes | July 8, 2014

Life Science Industry Events until Oct. Plus Jobs

I am sending highlights for the next two weeks, but you can download details for the events for the next three weeks. See at end of list.

I will be away for a month and not writing my blog again until Aug. 10. I took time to enjoy the Fourth of July weekend and then got very involved in preparing for my month absence. If you need to reach me during that time, send an email which I will be checking infrequently. I’m going offline as much as possible as I focus on other things.

If you are interested in keeping up with life science industry developments, check out the Battelle Report at http://goo.gl/RhjlDo . Ernst and Young has just published their review of biotech for 2013 in their annual report Beyond Borders. Find latter at http://www.ey.com/GL/en/Industries/Life-Sciences/Beyond-borders-Matters-of-evidence-biotechnology-industry-report-2013—Point-of-view-matters-of-evidence. The latter is excellent in that it provides continuity over 25 years with the same definitions used during the history of biotechnology.

  • BioCentury This Week, See new program Webcast Starting Sunday, July 7, 2014, http://www.biocenturytv.com, Available anytime starting at 9:00 a.m. EDT; Topic: “Will Truvada Prevent AIDS;” Speakers: Dr. Richard Elion, Clinical Research Director at the Whitman-Walker Clinic, the largest AIDS healthcare provider in Washington D.C.; Tom Myers, Chief of Public Affairs and General Counsel for the AIDS Healthcare Foundation; and Dr. Joel Kupersmith, former Head of Medical Research at the Veterans Health Administration
  • Bio2Device Group, Tuesday Evening, July 8, 2014, Event: “Ca2+ Sensitizers – Opportunities in Drug Development;” Speaker: Ullrich Steven Schwertschlag, M.D, PHD, FACP, FCP , Pharmaceutical Drug Developer
  • Medtech Frontiers, Thursday Evening, July 10, 2014; Topic: “Bring Joy to Medical Technologies with Anthropology;” Speaker: Richard Sheridan, co-founder of Menlo Innovations
  • Bio2Device Group, Tuesday Morning, July 15, 2014; Topic: “Challenges in Developing Drugs for Orphan Indications: The Story of Neuraltus and ALS;” Speaker: Richard L. Casey, President and CEO, Neuraltus Pharmaceuticals
  • WIB-San Francisco Bay Area, Thursday Evening, July 17, 2014; Event: “Chocolate and Talk a Lot!”
  • NCC ACRP, Thursday Evening, July 17, 2014; Event: Peninsula Networking Event

You can find the complete list of events included in Audreys picks July 8, 2014 with full details and the latest list ofJobsThatCrossedMyDeskThrough July 8, 2014 by right clicking on the bolded titles or on my blog found at www.Audreysnetwork.com.

 

Audrey

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: